AdvoCare Goes To Court

AdvoCare Reviews | Distributors Take AdvoCare To Court For Cancelling Account

For those of you who don’t know what type of MLM company is AdvoCare, basically they are a health and wellness company specializing in sports performance and weight-loss products. (read more here)

Herbalife $15 million settlement of a class-action lawsuit

A Los Angeles federal judge signed off on a $15 million settlement of a class-action lawsuit brought by a former Herbalife Ltd. salesman who alleged the Los Angeles-based nutrition company was operating a pyramid scheme that victimized hundreds of thousands of people a year.

In a 60-page written opinion issued late Thursday, U.S. District Judge Beverly Reid O’Connell called the settlement “fair, adequate and reasonable.”

The lawsuit, filed two years ago, alleged that Herbalife is a pyramid scheme in which the company’s independent distributors earn more money recruiting new sales people than they do selling its products, an allegation Herbalife has repeatedly and vigorously denied.

Advanced Joint Formula capsules may contain undeclared diclofenac and chlorpheniramine

G&C Natural Nutrition, Inc. Issues Voluntary Nationwide Recall of Pyrola Due to Undeclared Drug Ingredients

FOR IMMEDIATE RELEASE — June 12, 2015 — Fullerton, CA — G&C Natural Nutrition, Inc. is voluntarily recalling all lots of Pyrola, 430mg/capsule. Advanced Joint Formula capsules may contain undeclared diclofenac and chlorpheniramine.

Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. Chlorpheniramine is an over-the-counter (OTC) antihistamine used for allergies. Antihistamines may cause drowsiness and affect

mental alertness.

Pyrola Advanced Joint Formula contains hidden drug ingredients

While Pyrola Advanced Joint Formula is not technically a "weight loss" product, many of those that do take weight loss products suffer from joint pain, inflammation, and other similar symptoms.

Public Notification: Pyrola Advanced Joint Formula contains hidden drug ingredients

[6-5-2015] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Pyrola Advanced Joint Formula, a product promoted for joint pain and sold on various websites, including www.amazon.com, and in some retail stores..Image of Pyrola

FDA laboratory analysis confirmed Pyrola Advanced Joint Formula contains diclofenac. Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.

Laboratory analysis also confirmed that Pyrola Advanced Joint Formula contains chlorpheniramine. Chlorpheniramine is an over-the-counter (OTC) antihistamine used for allergies. Antihistamines may cause drowsiness and affect mental alertness.

SmartLipo365

SmartLipo365 Issues Voluntary Nationwide Recall of Smart Lipo Due to 

Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein

FOR IMMEDIATE RELEASE — June 3, 2015 — Dallas, TX,

SmartLipo365 is voluntarily recalling 122 lots of Smart Lipo (800, 900, 950 mg) capsules, to the consumer level. FDA received samples of 800 and 900mg capsules of Smart Lipo and the lab results found the Smart Lipo products to contain undeclared sibutramine, desmethylsibutramine, and phenolphthalein.

Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

Phenolphthalein is an ingredient previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is not currently approved for marketing in the United States. Health risks associated with phenolphthalein could include potentially serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use.

These undeclared ingredients make these products unapproved new drugs for which safety and efficacy have not been established.
These products may also interact in life-threatening ways with other medications a consumer may be taking.